''red tides'' or blooms of the organism, numerous fish Brevetoxins (PbTx) are a family of marine polyether and marine animals in the Gulf of Mexico, the southtoxins that exert their toxic action by activating volt-eastern seaboard of the United States, and other temage-sensitive sodium channels. Two forms of bre-perate marine environments succumb to the toxin (1). vetoxin, PbTx-2 and -3, induce hepatic cytochrome Human consumption of tainted shellfish is associated P4501A1, measured as ethoxyresorufin O-deethylase with a serious intoxication syndrome, neurotoxic shell-(EROD) activity, in redfish and striped bass. P4501A1 fish poisoning, the result of binding of brevetoxin induction is transcriptionally regulated through the (PbTx) to site 5 of the voltage-sensitive sodium channel binding of a ligand, typically a planar aromatic com-(VSSC).
common physical feature: they contain at least one aromatic carbon ring. Interestingly, the specific inducing brevetoxins, PbTx-2 and -3, are polyether ladder toxins ( Fig. 1) which are not aromatic. Further, computer modeling studies have shown these compounds to be nonplanar (2, 3). If PbTx-2 and/or -3 induce P4501A1 activity via the AhR-dependent mechanism, then this would represent a novel and potentially important observation. Here, we describe studies of the mechanism by which PbTx induces P4501A1 activity and demonstrate an interaction between PbTx and the AhR.
MATERIALS AND METHODS
Chemicals. Solutions of three forms of brevetoxin, PbTx-2, -3, and -6 ( Fig. 1) , and b-naphthoflavone (BNF) were prepared in DMSO. Because PbTx is a potent neurotoxin, extra precautions were taken when handling lyophilized toxin. These included the use of a respirator, gloves, and protective clothing. PbTx-2, an aldehyde; PbTx-3, an alcohol; and PbTx-6, an epoxide were diluted to various concentrations in DMSO appropriate for each assay. All three are naturally occurring forms of brevetoxin produced by P. brevis. Culture and purification of the PbTx-2 and -3 have been described (6) . Since PbTx-6 is in low abundancy naturally, it was chemically synthesized from PbTx-2 using dimethyldioxorane to oxidize the double bond on the eight-membered ring (ring H) (3). BNF was purchased from Sigma Chemical (St. Louis, MO).
[ care.
Animals and preparation of cytosol.
Male Hartley guinea pigs [250-300 g; Michigan Department of Public Health (Lansing, MI)] were exposed to a 12:12 light:dark cycle daily and were allowed free Following ligand binding, the ligand-AhR complex is access to food and water. Hepatic cytosol was prepared in HEDG buffer [25 mM Hepes, pH 7.5, 1 mM EDTA, 1 mM DTT, and 10% (v/ transformed into its DNA binding form and accumuv) glycerol] as previously described (13) and was stored at 080ЊC lates within the nucleus. After dimerization with a secuntil use. Protein concentrations were determined by the method of ond protein (ARNT, Ah receptor nuclear translocator), Bradford (14) , using bovine serum albumin as the standard. the AhR complex binds to DNA. The interaction of the AhR ligand binding assay. Specific binding of ligands to AhR was ligand-AhR-ARNT complex with its specific DNA rec-measured using hydroxyapatite adsorption (HAP) (15) and sucrose ognition site, the dioxin response element (DRE), re-density gradient assays (10) . For HAP assays, diluted guinea pig cytosol, containing the AhR (8 mg protein/ml HEDG buffer), was sults in transcriptional activation of an adjacent proincubated at 25ЊC on a rotating shaker for 2 h with [ 3 H]TCDD and moter and gene (CYP1A1 in this case) (7, 8 to the AhR was actually due to competitive inhibition Gel retardation analysis. A complementary pair of synthetic oli-by PbTx-6, sucrose density centrifugation analysis was gonucleotides containing the sequence 5-GATCTGGCTCTTCTC-carried out (Fig. 3) . The single [ H]TCDD and various concentrations of BNF, PbTx-2, PbTx-3, or PbTx-6 for 2 to the AhR by 72% of that observed with TCDBF. Overh at 25ЊC, followed by gel retardation analysis. In the binding assay, all, the above data confirm that PbTx-6 is a ligand of cytosol was mixed with poly(dI-dC) and incubated for 15 min at 25ЊC, followed by the addition of the AhR, but to transform it into its DNA binding form.
TCDD was also performed for comparative purposes.
Although this assay does not confirm the ability of the chemical to alter gene expression, the high degree of RESULTS correlation we have observed between the ability of a chemical to induce AhR transformation/DNA binding AhR binding assays. To assess the ability of several and gene expression would strongly support its AhR brevetoxins (PbTx-2, -3 and -6) to bind the AhR, saturaagonist activity. tion binding assays using [
H]TCDD were carried out
To examine the ability of the various PbTxs to induce using HAP binding assays. BNF, an AhR ligand used AhR transformation and DNA binding, we carried out as a positive control, and PbTx-6, but not PbTx-2 or GRA using 1-100 mM PbTx-2 and -3, 1-1000 nM PbTxPbTx-3, inhibited [ of the initial assay using 5 nM TCDD are shown in in the assay (lanes 4, 5, and 6). These results confirm that the protein-DNA complex induced by BNF and Fig. 4 . The arrow indicates the typical retarded band associated with TCDD-AhR-DRE complex formation. PbTx-6 represented the binding of transformed AhR complex to the DRE and was not associated with nonThe data in Fig. 5 revealed that nanomolar concentrations of BNF induced AhR-DRE complex formation, specific DNA binding. whereas only minimal complex formation was seen with micromolar concentrations of PbTx-2 and -3. DISCUSSION These results suggest that PbTx-2 and -3 are, as anticipated, weak AhR ligands. In contrast, PbTx-6 induced Previous research with redfish and striped bass demonstrated increased EROD activity in fish exposed to protein-DNA complex formation in a concentrationdependent manner with a potency similar to that of brevetoxin (5, 6); however, the mechanism by which this occurred was not examined. PbTx-2 and -3 are the BNF (Fig. 6) .
To confirm that the protein-DNA complex induced most abundant forms of brevetoxin in nature and we initially thought that they were the forms responsible by PbTx-6 and which migrates to the same position as that induced by BNF represents the AhR-DRE com-for EROD induction. However, the present series of experiments demonstrates that they play little if any plex, we examined the DNA binding specificity of the complex. The ability of the two ligands to induce pro-role in the AhR mechanism of P4501A1 induction. In HAP adsorption binding assays, PbTx-2 and -3 failed tein-DNA complex formation with both wild-type and mutant DRE containing oligonucleotides was com-to cause inhibition of [ We have previously demonstrated that a mutant DRE containing a single nucleotide substitution within strated specific binding of PbTx-6 to the AhR, it remained to be demonstrated if this form of brevetoxin the core DRE sequence prevents complex formation. As shown in Fig. 7 , the expected inducible protein-DNA acted as a AhR agonist or antagonist. If PbTx-6 induced a conformational change which prevented the PbTx-6-complex was observed when the wild-type DRE was used (lanes 1, 2, and 3), whereas the inducible complex AhR from complexing with the DRE, then it could not be responsible for the induction of EROD observed in could not be identified when the mutant DRE was used (Fig. 2) . The ability of PbTx-6 to compete with TCDD for ligand binding is of the same magnitude seen with other AhR ligands, such as benzo[a]pyrene and 3-methylcholanthrene (100 and 10 nM BaP and 3-MC respectively with 10 nM [ 3 H]TCDD) (18) . Poland and Glover reported a positive relationship between relative AhR binding affinity and relative biological potency among dibenzo-p-dioxin congeners (19) . This analysis, if applied to the three brevetoxins, would suggest that PbTx-6 is the form responsible for CYP1A1 induction.
The results of the gel mobility shift assays confirmed the findings of the receptor binding studies, i.e., PbTx-6 induced a gel shift. The ability of PbTx-6 to cause a concentration-dependent shift suggests that the toxin also causes conformational changes in the AhR that promote DRE complex formation which would be ex- previous experiments. When analyzed by gel retardation assays, a concentration of 100 mM PbTx-2 and -3 was necessary to observe a shift in mobility (Fig. 5) . This contrasts sharply with BNF for which a shift was observed at 10 nM. The very large concentration of PbTx-2 or -3 needed to induce complex formation suggests it is unlikely to have an effect in vivo. LD 50 for PbTx-2 and -3, the most toxic forms of brevetoxin (1), is approximately 5000-fold less than the concentration which induced a shift, suggesting that it is highly unlikely that these forms of brevetoxin could be responsible for EROD induction noted in the sublethal exposures of redfish and striped bass to brevetoxin in previous experiments (5) .
In contrast, PbTx-6 acted as a AhR competitive inhibitor of TCDD, both with HAP adsorption and sucrose specific binding to the AhR; in this case 79% inhibition produced three polar metabolites, suggesting that biotransformation of PbTx-2 occurs in fish (Washburn and Jones, unpublished observations). Although at present we have not positively identified these metabolites, epoxides are often a minor product of Phase I metabolism (21). Therefore, epoxidation of the H ring on PbTx-2 could occur as a consequence of P450 activity. The preliminary data we have in animals and the fact that PbTx-6 is produced in plants suggest that PbTx-6 is probably formed in vivo in vertebrates.
Most epoxides are highly labile compounds and are susceptible to nucleophilic attack from the face opposite the oxygen, resulting in opening of the epoxide ring. However, PbTx-6 does not appear to behave in this typical fashion. Our attempts to subject it to nucleophilic ring opening have not been successful (results not shown). This epoxide appears to be quite stable. Inspection of the three-dimensional models of the molecule reveals that the face of the epoxide opposite the oxygen (a) is sterically hindered and inaccessible to nucleophiles. In vivo, PbTx-6 might be sufficiently stable to allow it to bind to the AhR, induce CYP1A1, and produce the increased EROD activity that we have observed.
Our results show that PbTx-6 acts as an Ah receptor agonist, not an antagonist. PbTx-6 competes with PbTx-6 also caused complex formation with the DRE pected to induce P4501A1 gene expression. Taken together with the receptor binding studies, these data strongly suggest that PbTx-6 is responsible for the induction of P4501A1. It is possible, however, that one of the untested forms of PbTx might be involved in the observed response. PbTxs have two structural backbones, PbTx A and B, that contain minor variances in the carbon ring structure. PbTx-2, -3, and -6 are variants of the A backbone. It is possible that other variants of the PbTx A or either of the two forms of PbTx B could account for our findings. However, it should be noted that all forms of PbTx are nonplanar and nonaromatic.
PbTx-6 is roughly fivefold less toxic than PbTx-2 or -3 to mosquito fish (Gambusia affinis); LC 50 is 77 nM for PbTx-6 and 14-15 nM for PbTx-2 and -3. Furthermore, PbTx-2 has a roughly sixfold lower K d at site 5 of the VSSC than PbTx-6 (2). Although the binding affinity is lower for the epoxide, its K d is still significant (43 nM), and this molecule is considered quite toxic. At this point, it is not known if PbTx-6 is a human or animal patic microsomes and an NADPH regenerating system suggests it acts as an agonist, although the effect of (25, 26). For example, PCBs with high electron affinity, but low lipophilicity and entropy, are more toxic than PbTx-6 on gene expression remains to be confirmed. However, almost all chemicals we have analyzed that those with the reverse characteristics (26) . With regard to the brevetoxins, PbTx-6 is less lipophilic than PbTxproduce an inducible gel shift also induce gene expression (M. Denison, unpublished observations). BNF 2 or -3. The relative retention time of PbTx-6 on C 18 reverse-phase HPLC using a 85% methanol mobile acted in a similar fashion and is a well-recognized AhR agonist. In contrast, its isomer, a-naphthoflavone phase is about one-half that of the other congeners of brevetoxin. Thus, lower lipophilicity may be an im-(ANF), has antagonist activity (15, 22, 23) and competes with TCDD and BNF for AhR binding but with portant factor allowing PbTx-6 to act as an AhR ligand while other forms of PbTx apparently do not share this significantly lower affinity. At relatively low concentrations (õ10 mM), ANF competes with TCDD and BNF same characteristic.
In conclusion, this study suggests that PbTx-6 is to inhibit their ability to induce gel shifts and gene expression. At concentrations greater than 10 mM, how-responsible for the induction of EROD activity observed in previous work. The toxin is a ligand of the ever, ANF can act as a partial agonist. BNF, on the other hand, binds to the Ah receptor in a competitive AhR and induces DRE complex formation. As one of the so-called ''orphan receptors,'' an endogenous limanner and induces complex formation in a concentration-dependent fashion, as indicated by the presence of gand has not been identified that binds to the AhR.
Although PbTx is not an endogenous ligand, the fact a retarded band that has the same mobility as TCDDAhR-DRE. Taken together, findings from this and pre-that PbTx-6 binds to the receptor suggests two potentially useful observations. First, it contributes a betvious work show that PbTx-6 acts similarly to BNF as an AhR agonist.
ter understanding of the characteristics of AhR ligands. Second, it is potentially another piece in the One of the interesting aspects of these results is the demonstration that a nonplanar, nonaromatic molecule puzzle regarding the evolution of the AhR. Phylogenetically, the AhR is first observed in jawed vertehas the ability to bind to the AhR and induce a classical P4501A1 response. All of the molecules that are known brate fish (27) . It has not been identified in animals lower on the evolutionary scale than these fish. In the ligands of the AhR contain aromatic rings and many exhibit planar conformation. Synthetic toxicants, such primordial oceanic environment, one that was full of plant life including primitive plants such as algae, it as TCDD, polycyclic aromatic hydrocarbons, heterocyclic amines, polychlorinated dibenzofurans, and certain may have been that the AhR played a role in enabling fish to metabolize natural toxins. It is possible that members of the polychlorinated biphenyl family, all contain aromatic rings. Natural products such as the an ability to detoxify marine algal toxins played a role in survival of fishes. The ability of these toxins phytochemicals harmane and tropolone, derived from wood pulp, and ultraviolet light photoproducts of the to bind to the AhR and begin the process of biotransformation and detoxification could have been imamino acid tryptophan also contain aromatic rings (11, 10) . Regardless of the origin of these inducers, all share portant in the success of fish in this environment.
Additional research with other forms of brevetoxin the common feature of containing at least one aromatic ring and induce P4501A1. and other marine toxins, such as saxitoxin and okadaic acid, will help shed additional light on this quesThe eight-membered H ring in brevetoxins is not planar nor is it aromatic. PbTx-2 and -3 may adopt one of tion. two conformations, the boat chair or crown, with the boat chair favored by 4.5 kcal/mol (2). Thus, the relative ACKNOWLEDGMENTS population, according to the Boltzman distribution, is tified within a 10 kcal/mol energetic window). Consequently, the epoxidation of PbTx-2 to form PbTx-6 does not change the overall shape of the brevetoxin back-REFERENCES bone. Thus, for brevetoxins, the shape of the molecule
